The global Single Use Probes & Sensors Market size 2026 was valued at USD 3.74 billion in 2025 and is projected to grow from USD 4.17 billion in 2026 to USD 9.96 billion by 2034, exhibiting a CAGR of 11.48% during the forecast period. The global Single Use Probes & Sensors Market has emerged as a critical segment within the broader biopharmaceutical and bioprocessing industry. Driven by the rapid adoption of single-use technologies, the market is witnessing robust growth as manufacturers increasingly shift away from traditional stainless-steel equipment toward disposable, contamination-free alternatives. According to Fortune Business Insights, the market is poised to register a significant compound annual growth rate (CAGR) throughout the forecast period, primarily fueled by the expanding biopharmaceutical manufacturing landscape and growing demand for efficient, cost-effective bioprocessing solutions.
Single-use probes and sensors are disposable devices deployed in bioreactors, fermenters, and other bioprocessing apparatuses to monitor and control critical process parameters in real time. Their key advantage lies in eliminating the need for traditional cleaning-in-place (CIP) and sterilization-in-place (SIP) procedures, thereby reducing contamination risks, lowering operational costs, and improving overall production efficiency. The COVID-19 pandemic acted as a significant growth accelerator, as the surge in vaccine and biologics manufacturing dramatically increased the adoption of single-use bioprocessing systems globally.
Market Segmentation by Type
Based on type, the market is segmented into pH sensors/probes, pressure sensors/probes, temperature sensors/probes, conductivity sensors/probes, oxygen & CO2 sensors/probes, flow sensors/probes, and others.
- pH Sensors/Probes hold the largest market share throughout the forecast period due to their widespread usage and highest availability. As noted in the Pharmaceutical Bioprocessing Journal (January 2023), pH probes are among the most commonly used electrochemical sensors for bioprocess monitoring and control. Their increased deployment in bioreactors is a primary growth driver.
- Oxygen & CO2 Sensors/Probes are projected to grow at a substantial CAGR. Dissolved oxygen (D.O.) level measurement is a critical physicochemical parameter in bioprocessing engineering. In October 2023, Hamilton Company launched the VisiFerm SU, a redesigned dissolved oxygen sensor for single-use applications, reflecting growing market interest in this segment.
- Others (including viable cell density sensors) maintained a considerable share in 2023, owing to increasing demand for cell density monitoring during the cell production process.
Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/single-use-probes-sensors-market-109762
Regional Analysis
The market is geographically divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
- North America accounted for the largest market share in 2023 and is expected to maintain a significant CAGR throughout the forecast period. The region benefits from the strong presence of biopharmaceutical manufacturers. A notable development was Cardinal Health's expansion of its single-use device reprocessing facility in Riverview, Florida, to 100,000 square feet by November 2022, signaling robust regional demand.
- Europe remains a key contributor, driven by Germany's well-established biopharmaceutical industry and the UK's favorable regulatory frameworks that support the adoption of single-use technologies.
- Asia Pacific is anticipated to be the fastest-growing region, as countries like China and India emerge as hubs for biopharmaceutical outsourcing. In January 2023, Thermo Fisher Scientific unveiled a new manufacturing facility in China leveraging single-use technologies, highlighting the region's expanding manufacturing capacity.
Key Market Drivers
- Rising Demand for Biopharmaceuticals — Growing production of monoclonal antibodies, vaccines, and cell & gene therapies necessitates precise, reliable monitoring capabilities.
- Shift to Single-Use Bioprocessing Systems — Manufacturers are adopting disposable technologies for faster turnaround, scalability, and lower capital expenditure.
- Regulatory Support — Regulatory bodies increasingly endorse single-use technologies for their ability to reduce cross-contamination risks and comply with Good Manufacturing Practices (GMP).
- Technological Advancements — Development of miniaturized sensors, wireless monitoring, and IoT-enabled real-time data collection is broadening market applications.
- COVID-19 Impact — The pandemic significantly boosted market growth through accelerated adoption of single-use systems for vaccine and therapeutic production.
Key Companies Covered
The Fortune Business Insights report covers key players including:
- Hamilton Company
- Broadley-James Corporation
- Aseptic Group
- Sartorius Stedim Biotech (Sartorius AG)
- Thermo Fisher Scientific Inc.
- Mettler-Toledo International Inc.
- Endress+Hauser Group
- PreSens Precision Sensing GmbH
- Parker Hannifin Corporation
- Eppendorf AG
These players are actively engaged in new product launches, strategic expansions, mergers & acquisitions, and R&D investments to strengthen their competitive positioning in the market.
Market Outlook
The Single Use Probes & Sensors Market is well-positioned for sustained expansion through 2032 and beyond. The convergence of biopharmaceutical growth, technological innovation, and regulatory tailwinds creates a highly favorable environment. The upstream processing segment—particularly cell culture monitoring using disposable pH and dissolved oxygen sensors embedded in single-use bioreactors—is expected to register the highest growth rates. Meanwhile, downstream processing applications, including inline real-time quality control sensors, are emerging as a significant growth frontier.
The increasing integration of Process Analytical Technology (PAT) initiatives and Industry 4.0 principles into bioprocessing workflows further supports demand for advanced single-use sensing solutions. As biopharmaceutical companies and contract manufacturing organizations (CMOs) scale up production to meet global therapeutic demand, the reliance on reliable, validated, and cost-effective single-use probes and sensors will continue to intensify.